| Contributing Authors |
|
xi | |
| Foreword to the First Edition |
|
xix | |
| Preface |
|
xxi | |
| Color Plates fall between pages 478 and 479 |
|
| Section I Strategies for the Use of Agents at High Dose |
|
|
Pharmacologic Strategies for High-Dose Therapy |
|
|
3 | (12) |
|
|
|
|
|
|
|
|
|
|
|
Preclinical Models for High-Dose Therapy |
|
|
15 | (34) |
|
|
|
|
|
|
|
|
49 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
What Is the Best Strategy for Autologus Hematopoietic Stem Cell Transplantation in Cancer? |
|
|
69 | (8) |
|
|
|
|
|
|
Strategies for the Use of Total-Body Irradiation as Stemic Therapy in Hematologic Malignancies |
|
|
77 | (32) |
|
|
|
|
|
|
|
|
109 | (14) |
|
|
|
|
|
|
Immune Adjuvant Therapy Post High-Dose Therapy |
|
|
123 | (16) |
|
|
|
|
|
|
|
|
|
|
|
A Health Policy Perspective on High-Dose Cancer Therapy: Cost, Effectiveness, and Cost-Effectiveness |
|
|
139 | (14) |
|
|
|
|
|
|
|
|
|
|
|
Quality of Life after Bone Marrow Transplantation |
|
|
153 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
167 | (18) |
|
|
|
|
|
| Section II Reestablishing Hematopoiesis after Dose-Intensive Therapy Transplantation |
|
|
The Hematopoietic Microenvironment |
|
|
185 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hematologic Reconstitution after Allogeneic Hematopoietic Cell Transplantation |
|
|
193 | (18) |
|
|
|
|
|
|
|
|
|
|
|
Allogeneic Core Blood Hematopoietic Stem Cell Transplants in Malignancies |
|
|
211 | (10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bone Marrow Transplantation Using Unrelated Donors |
|
|
221 | (22) |
|
|
|
|
|
|
|
|
|
|
|
Autologous Bone Marrow Transplantation |
|
|
243 | (30) |
|
|
|
|
|
|
Reestablishing Hematopoiesis with Peripheral Stem Cells |
|
|
273 | (10) |
|
|
|
|
|
|
Immunologic Reconstitution after High-Dose Chemoradiotherapy and Allogeneic of Autologus Bone Marrow or Peripheral Blood Hematopoietic Stem Cell Transplantation |
|
|
283 | (18) |
|
|
|
|
|
| Marrow Contamination |
|
|
Minimal Disease: Detection and Significance |
|
|
301 | (30) |
|
|
|
|
|
|
Negative and Positive Stem Cell Selection |
|
|
331 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stem Cell In Vitro Purging for Autologous Transplantation |
|
|
355 | (38) |
|
|
|
|
|
| Growth Factors |
|
|
Granulocyte-Macrophage Colony-Stimulating Factor |
|
|
393 | (18) |
|
|
|
|
|
|
|
|
|
|
|
Recombinant Human Granulocyte Colony-Stimulating Factor Support of Cancer Patient |
|
|
411 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
437 | (18) |
|
|
|
|
|
|
The Biology and Clinical Use of Stem Cell Factor |
|
|
455 | (12) |
|
|
|
|
|
|
|
|
|
|
|
Other Cytokines (IL-11, Thrombopoietin, flt-3 Ligand, and IL-3) |
|
|
467 | (12) |
|
|
|
|
|
| Section III Laboratory and Clinical Support for Dose-Intensive Therapy |
|
|
The American Society of Clinical Oncology and American Society of Hematology Recommended Criteria for the Performance of Bone Marrow Transplantation |
|
|
479 | (2) |
|
Nursing for Patients Receiving High-Dose Chemotherapy with Hematopoietic Rescue |
|
|
481 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
495 | (16) |
|
|
|
|
|
|
Blood Bank Support for Patients Undergoing High-Dose Chemotherapy |
|
|
511 | (24) |
|
|
|
|
|
|
|
|
|
|
|
Infectious Complications after High-Dose Chemotherapy |
|
|
535 | (22) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
557 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hepatic Complications of Bone Marrow Transplantation |
|
|
575 | (20) |
|
|
|
|
|
|
Cardiovascular System and High-Dose Therapy |
|
|
595 | (14) |
|
|
|
|
|
|
|
|
|
|
|
Multiple Organ Dysfunction Syndrome |
|
|
609 | (16) |
|
|
|
|
|
|
|
|
625 | (16) |
|
|
|
|
|
|
Genitourinary, Gastrointestinal, Endocrine, Nervous System, and Coagulation Complications |
|
|
641 | (8) |
|
|
|
|
|
|
|
|
649 | (18) |
|
|
|
|
|
| Section IV Clinical Applications of High-Dose Therapy |
|
|
High-Dose Therapy in Acute Myeloid Leukemia |
|
|
667 | (24) |
|
|
|
|
|
|
High-Dose Therapy in Acute Lymphoblastic Leukemia |
|
|
691 | (14) |
|
|
|
|
|
|
|
|
|
|
|
Chronic Myelogenous Leukemia |
|
|
705 | (28) |
|
|
|
|
|
|
|
|
|
|
|
Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia |
|
|
733 | (10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High-Dose Therapy in Multiple Myeloma |
|
|
743 | (12) |
|
|
|
|
|
|
|
|
|
|
|
High-Dose Therapy for Hodgkin's Disease |
|
|
755 | (20) |
|
|
|
|
|
|
|
|
|
|
|
High-Dose Therapy for the Treatment of Non-Hodgkin's Lymphoma |
|
|
775 | (22) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High-Dose Therapy in Burkitt's Lymphoma |
|
|
797 | (10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High-Dose Chemotherapy in Patients with Germ Cell Cancer |
|
|
807 | (14) |
|
|
|
|
|
|
|
|
|
|
|
Dose-Intensive Therapy for Breast Cancer |
|
|
821 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
841 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High-Dose Chemotherapy and Stem Cell Transplantation for Ovarian Cancer |
|
|
853 | (18) |
|
|
|
|
|
|
High-Dose Therapy and Stem Cell Transplantation for Neuroblastoma and Other Pediatric Solid Tumors |
|
|
871 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
895 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
909 | (12) |
|
|
|
|
|
| Index |
|
921 | |
Shopping Cart
Need Help? bookstore@ecampus.com
Copyright© 1999-2008
